Alimera Sciences appoints Skibsted as Chief Financial Officer, SVP

Alimera Sciences (ALIM) announced the appointment of pharma financial veteran Russell Skibsted, as Senior Vice President, SVP, and Chief Financial Officer, CFO, effective today, January 9, 2023. Skibsted is a seasoned pharma executive with nearly 30 years of experience in financial management, global business development, capital raises, investor relations, and operations. Prior to joining Alimera, he served as Executive Vice President, CFO and Chief Business Officer at Rockwell Medical (RMTI), a public company providing hemodialysis products.